InvestorsHub Logo
Followers 155
Posts 2641
Boards Moderated 0
Alias Born 01/29/2004

Re: rx7171 post# 389020

Monday, 12/05/2022 11:34:29 AM

Monday, December 05, 2022 11:34:29 AM

Post# of 462124
How will it be?

Expert in the field with no connection to the company saying “improvement” after looking at the data presented.

This is a major, focal point or consideration for eventual blarcamesine use as an Alzheimer’s therapy.

Consider the implications of this (if it’s true). If blarcamesine can either stop the progression of Alzheimer’s, or, even better, reverse it, how will either of those scenarios play out if the drug is administered at the earliest detection of the disease?

If blarcamesine therapy starts after the disease has set in and dementia symptoms are prominently present, merely slowing or halting disease progression would be only moderately favorable. Better than no treatment, but certainly not ideal.

But, understand, there are now emerging any number of new, accurate tests for Alzheimer’s vulnerability or pre-synaptic diagnosis.

“Mrs. Jones, we are sorry to report that the lab tests show that your mother, although presently in good mental health, is actually developing Alzheimer’s. You will need to make arrangements for her care at some time. Right now, there is little that we can do to prevent the intensification of her dementia symptoms that will start to appear.”

Or, “Fortunately, we now have this new drug, blarcamesine, which will either keep things as they are, or even actually improve your mother’s elderly slowness of thought. And, unlike the other Alzheimer’s drugs, it has no side effects. She’ll just need to take her tiny 50mg tablet just before she goes to bed.”

“Wait a minute! You’re not gonna push that stuff on my mom. I know better. On the internet there were dozens of medical experts, doctors even, who clearly pointed out that the clinical trial for that drug produced unclear, confusing, and questionable results. And the guy that runs the company can’t speak English clearly. I’m keeping my mom safe!”

Simple. Early, prodromal administration of blarcamesine has the distinct, game-changing possibility of preventing the onset or development of severe Alzheimer’s debilitation.

With a different patient: “How’s your mother, after they detected that she’s gonna get Alzheimer’s?”

“Well, let me tell ya. It’s been two years now and Mom is more alert than ever before. She’s like a bright young lady. And, believe it or not, she’s now sleeping like a child each night. She wakes up well-rested and lives actively all day; until just before bed when she has to take her little pill.”
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News